Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA Share Price    (JUBOL)

Here is the latest stock price and chart of Jubilant Pharmova. For more details, see the Jubilant Pharmova company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since small-cap stocks interest you, here's a proven approach on investing in small-cap stocks.

Revealed: 3 Stocks for Potentially Massive Gains

REFRESH
Live BSE Quotes Apr 12, 2021 10:22:00 AM
Price (Rs)779.60 Open (Rs) 754.90 High (Rs) 792.50 Low (Rs) 705.00
% Change5.86 Volume 41,619 Value (Rs) 32,446,172 52-Week H/L 1,046.75 / 325.00
Live NSE Quotes Apr 12, 2021 10:24:56 AM
Price (Rs)775.20 Open (Rs) 751.00 High (Rs) 793.05 Low (Rs) 738.00
% Change5.33 Volume 309,406 Value (Rs) 238,202,397 52-Week H/L 1,046.95 / 234.35
Change
1 Day
5.86%
1 Month
-0.28%
3 Months
-15.86%
1 Year
126.30%
5 Years (CAGR)*
14.30%
10 Years (CAGR)*
15.11%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 56.39 P/E Ratio (x) 13.82 Market Cap (Rs m) 124,174.69 P/BV (x) 2.58
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

JUBILANT PHARMOVA Share Price Today:

JUBILANT PHARMOVA share price has surged 5.9% to Rs 779.6 on the BSE. On the NSE, the JUBILANT PHARMOVA share price has surged 5.3% to Rs 775.2. The total volume of shares traded is 0.4 m.

Overall, the broader S&P BSE HEALTHCARE Index is trading up by 0.9%. And the benchmark S&P BSE SENSEX is at 48,241.3 (down 2.7%).

Over the last 30 days, the JUBILANT PHARMOVA share price is up 3.7%. And over the last one year, JUBILANT PHARMOVA share price is up 140.4%.


What else is happening in the markets today? Dig in...


Today's Market

Sensex Slumps 1,400 Points, Nifty Cracks Below 14,400; IndusInd Bank & SBI Fall 8%(09:30 am)

Asian stock markets are trading on a cautious note today as investors wait to see if US earnings can justify sky-high valuations.

Related Views On News

JUBILANT PHARMOVA Share Price Up by 6%; BSE HEALTHCARE Index Up 0.6% (Market Updates)

Apr 12, 2021 | Updated on Apr 12, 2021

JUBILANT PHARMOVA share price is trading up by 6% and its current market price is Rs 786. The BSE HEALTHCARE is up by 0.6%. The top gainers in the BSE HEALTHCARE Index are JUBILANT PHARMOVA (up 6.2%) and IPCA LABS (up 5.3%). The top losers are GLENMARK PHARMA (down 0.1%) and ALEMBIC PHARMA (down 0.2%).

MPHASIS at 52 Week High; BSE 500 Index Down 2.6% (Market Updates)

Apr 12, 2021 | Updated on Apr 12, 2021

MPHASIS share price has hit a 52-week high. It is presently trading at Rs 1,836. BSE 500 Index is down by 2.6% at 19,671. Within the BSE 500, MPHASIS (up 0.5%) and JUBILANT PHARMOVA (up 6.2%) are among the top gainers, while top losers are RBL BANK and RELIANCE POWER.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 24.0% YoY). Sales on the other hand came in at Rs 23 bn (down 2.6% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

More Views on News

Most Popular

A Critical Update on the Market (Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis (Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy (Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers (Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA 8-QTR ANALYSIS

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS